Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

GlaxoSmithKline UK
Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 14/06/2011
PIL Malarone

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 14/06/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 29/10/2010 and displayed until 14/06/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change of manufacturer
Updated on 08/09/2009 and displayed until 29/10/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 03/09/2009 and displayed until 08/09/2009
Reasons for adding or updating:
  • Change to appearance of the medicine
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 18/03/2009 and displayed until 03/09/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 28/07/2008 and displayed until 18/03/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 03/06/2008 and displayed until 28/07/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 17/03/2008 and displayed until 03/06/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change to drug interactions
  • Change due to harmonisation of patient information leaflet
  • Change due to user-testing of patient information
Updated on 19/10/2007 and displayed until 17/03/2008
Reasons for adding or updating:
  • Change to drug interactions
  • Change to side-effects
  • Change to date of revision
Updated on 29/03/2005 and displayed until 19/10/2007
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 07/12/2004 and displayed until 29/03/2005
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
  • Change to information about driving or using machinery
Updated on 15/01/2003 and displayed until 07/12/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 14/08/2002 and displayed until 15/01/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 24/09/2001 and displayed until 14/08/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 15/05/2001 and displayed until 24/09/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 09/02/2001 and displayed until 15/05/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  atovaquone
  proguanil hydrochloride